Share >  
Share
Share on Tumblr

Clinical Data

News »

   latest by relevance
Roche drug improves vision in diabetic eye disease
Jun 29, 2011 at 08:16 | Source: Reuters
Diabetic patients with a vision-robbing eye condition who were treated with Roche's Lucentis had significant and sustained vision improvement compared with those who received a placebo, according to data from a pair of pivotal clinical trials.
Biocon: Oral insulin fails to meet primary target
Jan 11, 2011 at 10:45 | Source: Reuters
Biocon on Tuesday said initial data from late-stage clinical trials on its experimental oral insulin drug for diabetes did not meet the desired results, but said it was committed to the global development of the drug.
No new conclusions on Glaxo's Avandia yet: US Fed
Feb 23, 2010 at 09:54 | Source: Reuters
The US Food and Drug Administration is reviewing data on possible heart risks with GlaxoSmithKline Plc's diabetes drug Avandia but has not reached any new conclusions, the agency said on Monday.
Clinsys Clinical Research buys TrialStat ClinicalAnalytics
Nov 22, 2008 at 11:55
Jubilant Organosys Ltd. announced today that its subsidiary, Clinsys Clinical Research, Inc., New Jersey, USA, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics from TrialStat for a purchase consideration of CAD 750,000
Veeda Clinical Research implements Clintrial
Sep 18, 2008 at 16:50
Veeda Clinical Research, a fast growing Clinical Research Organization with presence in Europe, India and USA, has announced the implementation of Clintrial, a leading Clinical Data Management tool to strengthen its Data Management backbone
Tests support oral insulin, says Biocon
Sep 09, 2008 at 08:57 | Source: Business Line
Biocon Ltd, in a race to develop the worlds first non-injection insulin pill, said its breakthrough oral drug under development has showed encouraging results from human clinical data.

Photos »

  /  
News across the web »
Drug firms lay onus of medicine approvals at DCGI door-step
Mumbai, May 11: The onus of granting approvals to medicines marketed in the country is on the regulator, the Drug Controller General of India (DCGI), say drug companies, adding that they have adhered...
May 12, 2012 at 02:42 | Source: The Hindu BusinessLine
Drug cos lay onus of medicine approvals at DCGI door-step
Mumbai, May 11: The onus of granting approvals to medicines marketed in the country is on the regulator Drug Controller General of India (DCGI), say drug companies, adding that they have adhered to t...
May 11, 2012 at 10:21 | Source: The Hindu BusinessLine
SUNY Searches Big Data For Multiple Sclerosis Causes
SUNY Buffalo entrance sign (Photo credit: Wikipedia) Researchers at SUNY Buffalo are examining the links between the exposure to sunlight and Vitamin D in Multiple Sclerosis (MS), a chronic neurologi...
May 03, 2012 at 04:32 | Source: Forbes
Aurora Health Uses Big Data to Reduce Risk in Outcomes-Based Pay
Aurora Health Care in Wisconsin has invested in big data and a very fast data warehouse to improve its clinical results while reducing costs of treatment and cutting readmissions. It is well on the w...
Apr 20, 2012 at 23:21 | Source: Forbes
Hepatitis C drug stocks back in play
BOSTON (MarketWatch) — Hepatitis C drug stocks were back in play Thursday after Gilead Sciences and Idenix Pharmaceuticals rolled out promising data for their experimental drugs at a major medical ...
Apr 20, 2012 at 00:07 | Source: Market Watch
more »
Interact & exchange stock tips & market info »

MMB Messenger

Platinum Member

112633 Followers

Suven Life Scie  

Suven Life Sciences Ltd has informed BSE regarding a Press Release dat...

11.15 AM Nov 14th 2011

Related News »
Clinical data from Boston Scientific endoscopy studies to be presented at DDW
Boston Scientific Corporation (NYSE: BSX) announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week ® (DDW), May 19 – 22 in San Diego.  The analyses involve the SpyGlass ® Direct ...
May 19, 2012 at 10:27 | Source: News-Medical.Net
Pfizer's clinical data package for Tafamidis recommended by FDA Advisory Committee
May 25, 2012 (M2 EQUITYBITES via COMTEX) -- Global healthcare company Pfizer Inc PFE announced on Thursday that the US Food and Drug Administration's (FDA) Peripheral and Central Nervous System Drugs Advisory Committee has voted 13-4 on Pfizer's clinical ...
May 25, 2012 at 08:33 | Source: MENAFN
Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR
ST. PAUL, Minn. & PARIS--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced that significant clinical data for its structural heart portfolio is being presented during EuroPCR. Among the highlights are ...
May 15, 2012 at 23:54 | Source: Business Wire
DBV Technologies: First Quarter 2012 Topline, Scientific Activity and Upcoming Clinical Data
DBV Technologies (Paris:DBV) (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new standard in the treatment of allergy, announced today its first quarter topline and its intense scientific activity and clinical data disclosure ...
May 15, 2012 at 08:30 | Source: TMCnet
MorphoSys Reports Pre-clinical Data On Proprietary Drug Candidate MOR208
(RTTNews) - MorphoSys AG (MPSYY.PK: News ) reported promising pre-clinical data on its proprietary drug candidate MOR208, a potent anti-CD19 antibody with a proprietary modification to the Fc portion that is being developed to treat B-cell malignancies.
May 17, 2012 at 05:36 | Source: RTT News
Pulmatrix Announces Presentation of Clinical Data Demonstrating iCALM Inhaled Therapeutic Reduced Airway Inflammation
LEXINGTON, Mass.--(BUSINESS WIRE)--May 21, 2012 - Pulmatrix, a biotechnology company developing breakthrough therapies for respiratory diseases, today announced the results of a clinical study showing that an iCALM™ (inhaled cationic airway lining ...
May 21, 2012 at 18:39 | Source: Phramalive.com
Niiki Pharma to Present Phase I Clinical Data on Anti-Cancer Agent at ASCO
Niiki Pharma Inc. announced that results from the completed Phase I dose escalation trial of its GRP78 targeted anti-cancer agent, NKP-1339, will be presented at the Annual Meeting of the American Society of Clinical Oncology to be held in Chicago.
May 24, 2012 at 20:30 | Source: PRLog (free press release)
Cyclacel to Report New Sapacitabine Clinical Data at the American Society of Clinical Oncology Annual Meeting
BERKELEY HEIGHTS, N.J., May 17, 2012 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC - News) (Nasdaq:CYCCP - News) (Cyclacel or the Company), announced today that new clinical data for oral sapacitabine capsules, the Company's ...
May 17, 2012 at 10:58 | Source: Yahoo Finance
Sangamo BioSciences presents clinical data from ZFP Therapeutics at ASGCT meeting
Scientists from Sangamo BioSciences Inc. and collaborators has presented the data from clinical, preclinical and research-stage programmes focused on the development of ZFP Therapeutics for HIV/AIDS, monogenic diseases and stem cell applications at the ...
May 22, 2012 at 05:16 | Source: pharmabiz.com
One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston …
NATICK, Mass., May 15, 2012 /PRNewswire/ -- Boston Scientific Corporation (BSX) announces that the SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium Coronary Stent System demonstrated non-inferior results in treating ...
May 28, 2012 at 21:01 | Source: Yahoo Finance

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window